Personalized Precision Immune Therapy For Cancer
Personalized Precision Immune Therapy For Cancer
One of the most promising new treatments in the war against cancer. We provide results-oriented, experienced, and compassionate care to our patients because we feel that each patient is unique and deserves the highest level of personalized care.
How Can Immunotherapy Treat Cancer?
How Immunotherapy Can Treat Cancer?
How Immunotherapy Can Treat Cancer?
How Immunotherapy Can Treat Cancer?
Watch A Cancer Cell Being Destroyed With Immunotherapy
WHY CHOOSE THE
Maharaj Institute?
For more than 30 years, Dr. Maharaj has been pioneering immunotherapies we have been helping those who are seriously ill regain their immune function to fight and overcome aggressive diseases such as cancer, chronic inflammation, autoimmune diseases, and other chronic disorders. We also help individuals who may not have developed a disease and are proactively seeking solutions because of increased risk of developing disease.
Our Approach To Every Patient
Dipnarine Maharaj
MB.Ch.B.(Glasg.), MD (Glasg.), FRCP (Glasg.), FRCP (Edin.), FRCPath, FACP
Specializing in Internal Medicine, Hematology/Oncology/Immunology and Bone Marrow Stem Cell Transplantation, Dr. Dipnarine Maharaj is a pioneer in immunotherapy and bone marrow stem cell transplantation. For more than 30 years, he has worked with patients with severe immune dysfunction and cancer; most of them in a totally outpatient setting. He has published numerous medical articles, book chapters and he is a national and international expert in cancer care.
The Emerging Age of
Personalized Immunotherapy
The Emerging Age of
Personalized Immune Therapy
Current hematopoietic/progenitor stem cell therapies have been the standard of care for many disorders of the blood, immune system, and cancer. The application of cancer cell genomics and immunotherapy to fight cancer is the new field of medicine that is revolutionizing health care.
Cancer Conditions We Treat With Immunotherapy
Common Cancer Conditions
We Treat
Patient Case Studies
Patient Case Study
Patient Experiences Full Remission in Battle with Leukemia
Ann at age 56 was diagnosed with a very aggressive type of Chronic Lymphocytic leukemia and received conventional chemotherapy which was unsuccessful. She then turned to Dr. Maharaj and received personalized precision immunotherapy which resulted in a complete remission at a full hematological, cytogenetical and molecular level.
Recent news about the Institute, our patients, and advances in
personalized precision immunotherapy
Mark – Immune Regenerative Medicine with Dr. Maharaj
Mark was diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia. After facing a relapse of his disease following a bone marrow transplant in the United Kingdom, he turned to Dr. Maharaj for his immunotherapy treatment. Today Mark is leading a normal life with his beautiful family.
BREAST CANCER CASE STUDY
A 49 year old patient with Breast Cancer with persistent disease after surgery and chemotherapy turned to the Maharaj Institute.
The patient had a liquid biopsy test which showed ctDNA of guanine nucleotide-binding ?-subunit (GNAS) R201H mutation, which is associated with breast cancer.
Following the patient’s personalized precision immunotherapy, a liquid biopsy test showed no tumor-related somatic gene alterations. The patient breast cancer remains in complete remission.
BLADDER CANCER AND PROSTATE CANCER: PATIENT STORY
“I do credit Dr Maharaj with doing an excellent job of certainly improving my immune system, if not saving my life in the long term.
In December of 2020 I contracted Covid 19. While the initial disease was mild, no fever, didn’t lose taste or smell and only felt bad for 2 days, the long term effects were far more than I could have imagined.”
MORE CASE STUDIES
Ovarian Cancer
A 72-year-old woman with Ovarian Cancer turned to the Maharaj Institute after failing multiple rounds of surgery and chemotherapy.
The patient remains clinically well with no evidence of ovarian cancer for over 6 years since her recurrence in 2015, following the initiation of personalized treatment with low-dose immunotherapy and oral-targeted therapy.
Request An Appointment
Please fill out the form to request an appointment. We will contact you shortly to confirm the exact day/time.